| （単位：千ドル） | 1Q20 | 2Q20 | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,737 |
| 営業利益 | - | - | -28,630 | -38,934 | -48,534 | -47,101 | -42,812 | -39,812 | -27,526 | -35,883 | -25,388 | -28,672 | -18,050 | -17,378 | -20,702 | -16,459 |
| 純利益 | -17,585 | -27,172 | -28,531 | -38,882 | -48,435 | -46,915 | -42,811 | -39,542 | -26,701 | -34,338 | -23,856 | -27,110 | -16,711 | -15,991 | -19,340 | -15,405 |
| 一株あたり利益 | - | - | - | - | - | - | -0.79 | -0.73 | -0.49 | -0.63 | -0.44 | -0.49 | -0.3 | -0.26 | -0.31 | -0.25 |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | -0.79 | -0.73 | -0.49 | -0.63 | -0.44 | -0.49 | -0.3 | -0.26 | -0.31 | -0.25 |
| EBITDA | - | - | - | - | - | - | - |